WHEN WORLD HEALTH ENERGY HOLDINGS, INC.

Overview and Growth

WORLD HEALTH ENERGY HOLDINGS, INC. generated $166.03K of revenue in fiscal 2024, with net loss of $4.69M and an operating cash outflow of $1.45M. The $166.03K revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. The top line contracted 20.1% from $207.71K in fiscal 2023; this top-line contraction left the company with a smaller revenue base. On a per-share basis, diluted EPS was $0.00, which connects the reported earnings outcome with the company’s diluted share count. Diluted shares averaged 540.82B; this is the reported share base over which the company’s diluted per-share earnings were spread. The diluted share count was 4.0% higher than fiscal 2023, when diluted shares averaged 520.06B, adding context to the EPS comparison. At period end, total assets were $16.12M, framing the scale of the company’s operating and financing commitments. Asset turnover was 0.01x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

Gross profit was $62.66K, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 37.7% of revenue, showing how much of the top line remained after direct costs. The reported operating result was an operating loss of $4.09M, reflecting costs that exceeded gross profit. The bottom-line result was a net loss of $4.69M after operating, financing, tax, and other recognized items. EBITDA was negative $4.07M, showing a deficit before interest, taxes, depreciation, and amortization. The earnings statement records $4.90M of pretax income, the profit base against which the reported tax provision can be assessed. Relative to period-end equity, the net loss represented 82.8%. The loss-to-assets relationship was 29.1%, placing the bottom-line deficit against the company’s resource base. The net loss narrowed to $4.69M from $6.98M in fiscal 2023.

Liquidity and Capital Structure

At period end, the $16.12M asset base was financed through $5.45M of liabilities and $5.67M of equity. The near-term balance sheet paired $296.53K of current assets with $1.26M of current liabilities at the reporting date. Current assets covered only 0.23x of current liabilities, so current liabilities exceeded current assets at period end. Reported cash and equivalents were $63.19K, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 5.0% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 35.2% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 33.8% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 0.4%, comparing reported cash and equivalents with the full positive asset balance. Compared with $10.20M in fiscal 2023, the current asset base moved 58.0% and finished higher. Reported equity changed 10.4% from $6.33M in fiscal 2023, placing the current capital base lower year over year. Compared with $46.44K in fiscal 2023, the current cash balance moved 36.1% and finished higher.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $1.45M, rather than cash generation from operations. Capital expenditures used $6.95K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. The company recorded a $1.45M cash deficit after capital spending for the period. Free-cash-flow margin was -875.1%, reflecting a cash deficit equal to 875.1% of revenue after capital spending. The free-cash-flow deficit equaled 9.0% of total assets, placing the cash shortfall against the company’s resource base. Cash absorbed by operations increased from $1.07M in fiscal 2023 to $1.45M.

Based on the annual report for the fiscal year ending Dec 31, 2024. Analysis generated Oct 21, 2026.